If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
3
Followers on Owler
A1M Pharma
develops and commercializes medical applications based on the endogenous protein A1M...
Read more
Overview
Competitors
News & Insights
A1M Pharma
develops and commercializes medical applications based on the endogenous protein A1M...
Read more
CEO
Tobias Larsson Agervald
CEO Approval Rating
90/100
Weigh In
2008
Lund
Other
Private
Pharmaceuticals & Biotechnology
Biotechnology
2836
NAICS listing
http://www.a1m.se
Est. Annual Revenue
<$1M
Agree?
Yes
No
Est. Employees
<10
Agree?
Yes
No
News
Latest News
Sep 23, 2019
Cision
A1M Pharma: Redeye initiates coverage of A1M Pharma
Apr 08, 2019
FinanzNachrichten
A1M Pharma: Nasdaq Stockholm AB: New equity right for trading, A1M Pharma AB TO (129/19)
Nov 22, 2018
4-traders
A1M Pharma: A1M Pharma : receives observation status on Nasdaq First North
Sep 20, 2018
4-traders
A1M Pharma: A1M Pharma : re-submits application to the Swedish Medical Products Agency to conduct clinical trial with ROSgard
Aug 17, 2018
BioPortfolio
A1M Pharma: A1M Pharma AB A1M Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12042018 Prices from USD $250
Aug 15, 2018
BioPortfolio
A1M Pharma: A1M Pharma to prioritize the indication acute kidney injuries in further development of ROSgard on the basis of positive preclinical data
Aug 14, 2018
BioPortfolio
A1M Pharma: AIM Pharma appoints CMO as clinic nears for ROSgard kidney protection drug
Apr 19, 2018
FinanzNachrichten
A1M Pharma: Nasdaq Stockholm AB: Last day of trading in paid subscription shares (BTA) of A1M Pharma AB (134/18)
Mar 21, 2018
BioPortfolio
A1M Pharma: A1M Pharma AB A1M Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 19022018 Prices from USD $250
Mar 06, 2018
FinanzNachrichten
A1M Pharma: Nasdaq Stockholm AB: Trading in subscription rights and paid subscription shares in A1M Pharma AB (publ) (66/18)
Follow and Get Alerts
A1M Pharma Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 13 + competitors
Trending Companies